| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in CMMB over the last quarter tilts toward selling: insiders offloaded a net 2,304 shares worth roughly $7K.
Counted by filing, the last 12 months brought 1 open-market purchase by 1 insider worth about $20K and 1 sale by 1 insider worth about $7K. There were none in the 12 months before that either.
The largest open-market purchase in the last two years was 9,804 shares by George Adi Mor (Chief Executive Officer) at an average $2.07 on May 29, 2026, about $20K. Three months later CMMB was up 36%.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 33.0K | $41.0K | - | |
| CEO | 18.8K | $23.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Neil Harris Cohen | Director | Sell | 2,304 | $2.83 | $6,516.40 | -6.5% | - | - | |
| May 29, 2026 | George Adi Mor78 | Chief Executive Officer | Buy | 9,804 | $2.07 | $20,245.98 | +7.6% | +36.0% | - | |
| Jan 3, 2023 | George Adi Mor78 | Chief Scientific Officer | Sell | 13,800 | $5.03 | $69,369.84 | -5.2% | -49.0% | -81.8% | |
| Jan 3, 2023 | Orbimed Israel GP Ltd. | 10% Owner | Sell | 336,900 | $3.58 | $1,207,759.08 | -13.1% | -49.0% | -81.8% | |
| Nov 16, 2022 | Neil Harris Cohen | Director | Sell | 2,409 | $2.00 | $4,818.00 | -19.4% | -9.2% | -71.1% | |
| Nov 16, 2022 | George Adi Mor78 | Chief Scientific Officer | Sell | 582,023 | $2.08 | $1,213,401.55 | -69.3% | -9.2% | -71.1% | |
| May 24, 2022 | Joel Michael Maryles | Director | Buy | 433 | $2.88 | $1,247.08 | +43.3% | +15.7% | -39.6% | |
| May 18, 2022 | Neil Harris Cohen | Director | Buy | 2,000 | $3.19 | $6,380.00 | +19.2% | +21.9% | -39.9% | |
| Mar 18, 2022 | Joel Michael Maryles | Director | Buy | 1,000 | $4.34 | $4,340.00 | New | -27.5% | -67.2% | |
| Mar 16, 2022 | Donald Marvin | Executive VP, CFO & COO | Buy | 500 | $3.28 | $1,637.50 | +33.3% | -21.0% | -63.7% |